DOI:
10.1055/s-00000034
Klinische Pädiatrie
LinksClose Window
References
Ryan QC, Headlee D, Acharya M. et al.
Phase I and pharmacokinetic study of MS-275, a histone deacetylase inhibitor, in patients with advanced and refractory solid tumors or lymphoma.
J Clin Oncol 2005; 23: 3912-3922
We do not assume any responsibility for the contents of the web pages of other providers.